Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23261228 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia
Conditions: Precancerous Condition;   Stage I Non-small Cell Lung Cancer;   Tobacco Use Disorder
Interventions: Drug: sulindac;   Other: placebo

Indicates status has not been verified in more than two years